BioAdaptives Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioAdaptives Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $92.45K, a 71.20% increase year-over-year.
- BioAdaptives Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-30 was $40.59K.
- BioAdaptives Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $54.00K, a 1.53% increase year-over-year.
- BioAdaptives Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- BioAdaptives Inc. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $148.09K, a 26.92% decline from fiscal 2024.
- BioAdaptives Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $202.64K, a 28.17% decline from fiscal 2023.
- BioAdaptives Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $282.11K, a 45.92% decline from fiscal 2022.
- BioAdaptives Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $521.68K, a 39.10% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $92.45K 10-Q · filed 2026-08-19 | |
| 2025-12-31 | $148.09K 10-K · filed 2026-04-14 | |
| 2025-09-30 | $40.59K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $54.00K 10-Q · filed 2025-11-14 | |
| 2024-12-31 | $202.64K 10-K · filed 2026-04-14 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $53.19K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $149.46K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $282.11K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $178.10K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $96.06K 10-Q · filed 2024-11-19 | |
| 2023-03-31 | $108.04K 10-Q · filed 2024-11-19 | |
| 2022-12-31 | $521.68K 10-K · filed 2024-04-10 | |
| 2022-09-30 | $175.41K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $121.61K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $52.02K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $856.63K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $83.15K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $486.61K 10-Q · filed 2022-11-14 | |
| 2018-12-31 | $22.21K 10-K/A · filed 2020-05-12 | |
| 2018-09-30 | $1.75K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $18.76K 10-Q · filed 2019-08-14 |